Clinical Trials
Wednesday, March 6th, 2013
STROKEAHA: February 7, 2013 Background and Purpose—DP-b99, a lipophilic moderate-affinity chelator of zinc, was postulated to improve recovery after acute ischemic stroke. We evaluated the safety and therapeutic effects of DP-b99 in patients with acute hemispheric ischemic stroke. Methods—The Membrane-Activated Chelator Stroke Intervention trial was a randomized, double-blind, placebo-controlled, multicenter, parallel-group trial of intravenous DP-b99 administered […]
Clinical Trials
Tuesday, February 26th, 2013
J Am Heart Assoc.: February 19, 2013 Background Vitamin K antagonist (VKA) therapy remains the most common method of stroke prevention in patients with atrial fibrillation. Time in therapeutic range (TTR) is a widely cited measure of the quality of VKA therapy. We sought to identify factors associated with TTR in a large, international clinical trial. Read […]
Clinical Trials
Friday, February 22nd, 2013
NEJM: February 8, 2013 BACKGROUND Whether brain imaging can identify patients who are most likely to benefit from therapies for acute ischemic stroke and whether endovascular thrombectomy improves clinical outcomes in such patients remains unclear. Read more
Clinical Trials
Friday, February 22nd, 2013
American Heart Association: February 08, 2013 American Stroke Association Late-Breaking Science Report: Abstract LB 8 – Embargoed until 7 a.m. HT/ noon ET on Friday, Feb. 8, 2013 Study Highlights: Survivors of small-artery strokes who lowered their systolic blood pressure below 130 mm Hg were less likely to suffer a hemorrhagic stroke (bleeding in the brain) […]
Clinical Trials
Friday, February 22nd, 2013
American Heart Association: February 08, 2013 American Stroke Association Late-Breaking Science Report: Abstract LB 9 Embargoed until 7 a.m. HT/ noon ET on Friday, Feb. 8, 2013 Study Highlights: In patients who had endovascular therapy added to intravenous clot-busting drugs to restore blood flow after a stroke within seven hours, every 30-minute delay in breaking up […]
Clinical Trials
Friday, February 22nd, 2013
American Heart Association: February 08, 2013 American Stroke Association Late-Breaking Science Report: Abstract LB 11 Embargoed until 7 a.m. HT/ noon ET on Friday, Feb. 8, 2013 Study Highlights: Adding a second drug to aspirin therapy lowered the risk of a second stroke in the weeks after a clot caused minor stroke or TIA in Chinese […]
Clinical Trials
Friday, February 22nd, 2013
NEJM: February 7, 2013 BACKGROUND Endovascular therapy is increasingly used after the administration of intravenous tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic stroke, but whether a combined approach is more effective than intravenous t-PA alone is uncertain. Read more
Clinical Trials
Friday, February 8th, 2013
J NeuroIntervent Surg: Feb. 18, 2013 Abstract Objectives Endovascular therapy of acute ischemic stroke is evolving towards thrombectomy devices for vessel recanalization. High rates of revascularization have been reported in stroke device trials. However, the discrepancy between recanalization and outcomes raises the question whether patients with irreversible ischemic injury are being exposed to these interventions. This […]
Clinical Trials
Friday, February 8th, 2013
AHA: February 07, 2013 This news release is featured in a news conference at 7 a.m., HT, Thursday, Feb. 7. This news release contains updated numbers from the abstract. Study Highlights: A minimally invasive surgery appears safe and may reduce long-term disability after a bleeding stroke. If the findings are confirmed in a larger study, […]
Clinical Trials
Friday, February 8th, 2013
AHA: February 06, 2013 Study Highlights: Tai Chi exercise reduced falls among stroke survivors. The ancient Chinese martial art helped survivors achieve and maintain balance to aid stroke recovery. HONOLULU, Feb. 6, 2013 — Tai Chi may reduce falls among adult stroke survivors, according to research presented at the American Stroke Association’s International Stroke Conference 2013. […]
